Space bugs for blood testing – and more
Thanks to ideas of putting swarms of tiny robot bugs to work on a future space station, patients being medicated for blood clots may soon get a simple, home-use testing kit, here on Earth.
Fifteen years ago as a graduate student, Vladislav Djakov started building these micro-electromechanical creatures that mimic the swarms of bugs found in nature.
Equipped with a power supply, limited intelligence and monitoring systems, the bugs would be small enough to send en masse to hard-to-reach places, like pipes carrying liquids on space stations.
There, monitoring changes in temperature or flow could warn of impending malfunctions.
To move the bugs, the scientist hit on using cilia-like motion, much like some deep-sea creatures use to propel themselves. They covered one face of the microchip with tiny cantilever arms.
“They would then move along on these like millipedes,” said Dr Djakov, now Director of Sensor Development at Microvisk Technologies.
In the end, the space bugs were ahead of their time: they haven’t yet progressed past the testing phase.
But the cilia approach – the cantilever arms to propel the bugs – has gone further.
Space cantilevers spin off
STFC Innovation, ESA’s Technology Transfer Programme partner that operates the agency’s Business Incubation Centre Harwell in the UK, saw the business potential in the medical market and supported start-up company Microvisk to spin off the technology.
At Microvisk, Dr Djakov’s team stripped down the microchips and put the intelligent sensing mechanisms right into the cantilever arms, almost like a cat’s whiskers.
These whiskers turned out to be very good at monitoring liquids. Sweeping through, they note changes in viscosity and register if anything is suspended in the liquid.
“This is very interesting for probing blood, plasma, and other bodily fluids,” said Dr Djakov.
At present, investors are betting on a device to monitor blood coagulation for patients taking blood thinner medication: “It’s like a diabetes test, but for thrombosis.”
Thanks to this coagulometer, the Microvisk CoagLite, patients will soon be able to test themselves at home with the prick of a finger.
After a small chamber inside the test strip fills with blood, the tiny cantilever sweeps the drop, monitoring how quickly it coagulates.
“You need less blood, which means there is less pain,” said Dr Djakov, who compared its ease-of-use to diabetics’ simple glucose monitors. “Haematologists are finding it really important.”
Now undergoing clinical testing with US Food and Drug Administration, the coagulometer should be on the market later next year.
But the whisker technology isn’t limited to testing blood.
“It would be good for things like plasma or teardrops,” said Dr Djakov, “or to test the oil in a car engine, or in the food industry, to test chocolate or ketchup.
“There are literally hundreds of applications, for this innovation which started as a ‘space bug’.”
ESA’s Technology Transfer Programme Office (TTPO)
The main mission of ESA's Technology Transfer Programme is to facilitate the use of space technology and systems for non-space applications, and thereby also further demonstrating realising the benefit of the European space programmes to the citizens.
ESA TTPO is responsible for defining the overall approach and strategy for the transfer of space technologies and systems, including the incubation of start-up companies at ESA business incubation centres and related funding.
The office has transferred over 260 technologies since the programme start and is supporting directly and indirectly around 100 new start-ups a year. TTPO has also initiated as a limited partner the Open Sky Technology Fund, a €100 million venture fund which invests in start-ups using space technology.
For more information on TTPO, please contact: